NBIX vs PLUG · P/E 45, rev $2.36B vs rev $628.8M
Neurocrine Biosciences Inc (NBIX) versus Plug Power Inc (PLUG) — a side-by-side from cached financials, not a winner call.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Plug Power Inc (PLUG) is a electrical equipment & parts company listed on NASDAQ.
Latest reported NBIX revenue for 2024-12-31 was $2.36B. Net income was $341.3M. Revenue was up 24.8% from 2023-12-31 to 2024-12-31. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Latest reported PLUG revenue for 2024-12-31 was $628.8M. Net income was -$2.10B. Revenue was down 29.5% from 2023-12-31 to 2024-12-31. PLUG currently screens at market cap $3.70B.
NBIX currently screens at market cap $13.21B and trailing P/E 45.2. PLUG currently screens at market cap $3.70B.
Not investment advice. Open the NBIX and PLUG stock pages for the full models.
Not investment advice.